Mobile

Effects of OMACOR in patients with a cardiac sodium channel gene SCN5A mutation, one variant of the congenital long-QT syndrome. A proof of concept study

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-011819-20

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the effect of Omacor on the electrocardiographic QTc Fridericia interval in LQT3 patients (cardiac sodium channel gene SCN5A mutation leading to congenital long-QT syndrome).

Critère d'inclusion

  • Adult patients with a cardiac sodium channel gene SCN5A mutation, one variant of the congenital long-QT syndrome, with implantable cardioverter defibrillator (ICD)

Liens